Tavapadon (Juvmo) is a new once-daily pill for Parkinson’s motor symptoms. Here’s how it works, who it may help and what to ...

Changes in walking, mobility and balance can be frustrating symptoms of Parkinson’s disease. Join this month’s MJFF Parkinson’s Webinar to hear our panel of experts discuss why gait changes occur in ...

Michael J. Fox and Harrison Ford — two actors whose characters have raced through time, explored distant galaxies and, most recently, shared the screen on Apple TV’s award-winning series “Shrinking” — ...

Parkinson’s disease shares some movement symptoms with other parkinsonisms, but differs in significant ways. Join this MJFF Parkinson’s Webinar to learn how experts distinguish Parkinson’s disease ...

Variations in the LRRK2 gene are one of the strongest known genetic contributors to Parkinson’s. These variations cause overactivity in the LRRK2 protein pathway that ultimately damages dopamine ...

A new report released on March 26, 2026, by The Michael J. Fox Foundation (MJFF) shows that the annual economic impact of Parkinson’s disease and atypical parkinsonisms in the United States reached ...

A stem cell-based dopamine neuron replacement therapy for the treatment of motor symptoms in Parkinson’s disease (PD) has received conditional, limited approval for use in Japan, a first for this type ...

For people living with Parkinson’s disease — and for the families, friends and care partners who love them — progress depends not only on scientific discovery but also the public policies that help ...

A record number of today’s clinical trials are advancing therapies to slow Parkinson’s progression or to stop symptoms from getting worse. By targeting the biology that causes Parkinson’s, these drugs ...

As part of The Michael J. Fox Foundation’s goal to support the development of new and better Parkinson’s treatments, we are regularly assessing and tracking the drug development pipeline. Five areas ...

The U.S. Food and Drug Administration has approved a treatment that uses focused ultrasound on both sides of the brain (in two procedures, months apart) for the management of Parkinson’s-related ...